Director, HTA, Value & Evidence (HV&E) – Breast Cancer

ROLE SUMMARY

The Director, HTA, Value & Evidence (HV&E) – Breast Cancer will support the strategic goals of the Oncology Division by driving optimal patient access for Pfizer’s portfolio of breast cancer medicines, with a focus on Ibrance.

This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of our breast cancer medicines. The HV&E Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables.

This position will be part of Pfizer’s dynamic Global Access & Value (GAV) team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to breast cancer medicines, with a primary focus on Ibrance. This position will be working closely with the breast cancer GAV team, cross-functional and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and healthcare.

ROLE RESPONSIBILITIES

• Lead the development of the evidence generation strategy to support the value of breast cancer assets (Ibrance focus) in the Oncology Division, in close partnership with the cross-functional matrix team.
• Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the evidence strategy to support global market access needs to support upcoming launch and through lifecycle.
• Lead the design and execution of global HEOR studies (eg, network meta-analyses, non-interventional studies) from concept through publication.  
• Lead the timely development of launch deliverables including updating value & evidence strategy, global value dossiers/AMCP dossiers, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries.
• Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements. Provide strategic input into clinical trial designs (eg, patient populations, comparators, endpoints) and analysis to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
• Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs.
• Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• Graduate degree required (e.g. MSc, MPH, PhD)
• 7+ years of experience with MSc/MPH/MBA degree; 5+ years with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
• Demonstrated in depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis and interpretation. Capable of independently managing complex non-interventional study projects
• Knowledge and understanding of drug development process
• Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
• Excellent oral and written English communication skills
• Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
• An “execution mindset” focused on getting things done quickly and simply
• Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities